CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | -21.1% | 4,501 | +0.6% | 0.00% | – |
| Q2 2021 | $19,000 | -9.5% | 4,472 | +8.5% | 0.00% | – |
| Q1 2021 | $21,000 | +23.5% | 4,123 | +191.4% | 0.00% | – |
| Q1 2019 | $17,000 | -43.3% | 1,415 | -41.5% | 0.00% | – |
| Q4 2018 | $30,000 | -16.7% | 2,419 | 0.0% | 0.00% | – |
| Q3 2018 | $36,000 | -12.2% | 2,419 | 0.0% | 0.00% | – |
| Q2 2018 | $41,000 | -25.5% | 2,419 | 0.0% | 0.00% | – |
| Q1 2018 | $55,000 | -62.6% | 2,419 | -57.3% | 0.00% | -100.0% |
| Q4 2017 | $147,000 | +110.0% | 5,668 | +19.9% | 0.00% | 0.0% |
| Q3 2017 | $70,000 | +6.1% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $66,000 | -18.5% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $81,000 | +65.3% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $49,000 | – | 4,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,817,138 | $30,582,000 | 2.98% |
| SENZAR ASSET MANAGEMENT, LLC | 29,821 | $502,000 | 1.45% |
| INGALLS & SNYDER LLC | 1,337,862 | $22,516,000 | 1.04% |
| Matarin Capital Management, LLC | 316,858 | $5,332,720,000 | 0.39% |
| KNOTT DAVID M | 51,557 | $868,000 | 0.32% |
| PRINCETON CAPITAL MANAGEMENT LLC | 16,582 | $279,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 123,700 | $2,082,000 | 0.10% |
| Spark Investment Management LLC | 97,200 | $1,635,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 941,282 | $15,841,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 67,220 | $1,131,000 | 0.06% |